Biofunctional nanofibrous substrate comprising immobilized antibodies and selective binding of autologous growth factors

Catarina Oliveira, Ana R. Costa-Pinto, Rui L. Reis, Albino Martins, Nuno M. Neves*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

The immobilization of biomolecules at the surface of different biomedical devices has attracted enormous interest in order to enhance their biological functionality at the cellular level. This work aims to develop a biofunctional polymeric substrate capable of selectively binding growth factors (GFs) of interest from a pool of proteins present in a biological fluid: platelet lysate (PL). To achieve this goal, the surface of electrospun PCL nanofibers needs to be activated and functionalized to be able to insert chemical groups for the immobilization of antibodies. After determining the maximum immobilization capacity of each antibody, TGF-β1 (12 μg mL-1), bFGF (8 μg mL-1), and VEGF (4 μg mL-1), the next step was to confirm their bioavailability using recombinant proteins. The binding efficiency of PL-derived GFs was of 84-87% for TGF-β1, 55-64% for bFGF, and 50-59% for VEGF. Cellular assays confirmed the biological activity of the bound VEGF (both recombinant and PL-derived). Multiple antibodies (i.e., bFGF and VEGF) were also immobilized over the same structure in a mixed or side-by-side fashion. Using both autologous biological fluids and cells, it is possible to use this platform to implement very effective and personalized therapies that can be tailored to specific medical conditions.
Original languageEnglish
Pages (from-to)2196-2205
Number of pages10
JournalBiomacromolecules
Volume15
Issue number6
DOIs
Publication statusPublished - 9 Jun 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Biofunctional nanofibrous substrate comprising immobilized antibodies and selective binding of autologous growth factors'. Together they form a unique fingerprint.

Cite this